Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Time To Take A Second Look At Big Pharma
Seeking Alpha
Monday, August 29, 2011 - 5:44pm
tags:
Abbott Laboratories, Bristol-Myers Squibb, Merck, Eli Lilly, Pfizer
Power outages, floods close offices of drugmakers
Yahoo/AP
Monday, August 29, 2011 - 5:37pm
tags:
weather, Hurricane Irene, JNJ, GSK, Bayer, Teva Pharmaceuticals, Cephalon, Roche
Dendreon's Golden Age Is Still On Track
Seeking Alpha
Monday, August 29, 2011 - 1:43pm
tags:
Dendreon, Provenge, prostate cancer
Teva wins ruling in Copaxone patent lawsuit
Globes, Israel
Monday, August 29, 2011 - 1:14pm
tags:
Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis
Piramal to invest $1.5B in ex-India pharma
Fierce Pharma
Monday, August 29, 2011 - 1:13pm
tags:
India, Piramal Healthcare
FDA asks Novartis for more data on gout drug
Reuters
Monday, August 29, 2011 - 1:11pm
tags:
gout, FDA, Novartis, Ilaris
Gene Test For Pfizer Cancer Drug To Cost $1,500 Per Patient
Forbes
Monday, August 29, 2011 - 12:57pm
tags:
Pfizer, lung cancer, Xalkori
Johnson & Johnson: Best Valuation In 30 Years
Seeking Alpha
Monday, August 29, 2011 - 12:56pm
tags:
JNJ
Icagen says shareholders should support Pfizer's tender offer, as Pfizer won't raise bid
Yahoo/AP
Monday, August 29, 2011 - 12:54pm
tags:
Pfizer, Icagen, M&A
Pharma groups pay millions to US doctors
FT.com
Monday, August 29, 2011 - 11:06am
tags:
physician payments
Merck Wins Reversal In A Vioxx Lawsuit
Pharmalot
Monday, August 29, 2011 - 11:01am
tags:
Vioxx, Merck, lawsuits
Dendreon: The Challenge Of Misinformation
Seeking Alpha
Monday, August 29, 2011 - 11:00am
tags:
Dendreon, Provenge, prostate cancer
1-Star Stocks Poised to Plunge: Pharmasset?
Motley Fool
Monday, August 29, 2011 - 10:59am
tags:
Pharmasset
Analyst Says Xarelto Niche "Still Secure"
Forbes
Monday, August 29, 2011 - 10:57am
tags:
Xarelto, bloodthinners, Bayer, JNJ, Pfizer, Bristol-Myers Squibb, Eliquis
Pfizer, Bristol-Myers May Lead $9B Stroke Market
Bloomberg
Monday, August 29, 2011 - 10:56am
tags:
stroke, bloodthinners, Pfizer, Eliquis, Bristol-Myers Squibb
Ahead of the Bell: Analyst sees Pfizer drug growth
Yahoo/AP
Monday, August 29, 2011 - 10:55am
tags:
Pfizer, Xalkori, lung cancer, Abbott Laboratories
Vinita Gupta's entrepreneurial drive: Lupin now a big pharma player in the US
The Economic Times, India
Sunday, August 28, 2011 - 12:27pm
tags:
Lupin
Is Amgen's Stock a Bargain?
Motley Fool
Sunday, August 28, 2011 - 12:24pm
tags:
Amgen
Aspirin, Cheap Drugs Not Used Enough to Treat Heart Disease
Bloomberg
Sunday, August 28, 2011 - 12:24pm
tags:
heart disease, aspirin, statins, beta blockers
ELIQUIS® (apixaban) was Superior to Warfarin for the Reduction of Stroke or Systemic Embolism with Significantly Less Major Bleeding in Patients with Atrial Fibrillation in Phase 3 ARISTOTLE Trial
Yahoo/BusinessWire
Sunday, August 28, 2011 - 12:22pm
tags:
Eliquis, Apixaban, Warfarin, atrial fibrillation, stroke, Bristol-Myers Squibb, Pfizer, ARISTOTLE trial

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.